Oct 13, 2024
Since its inception, efforts to criminalize marijuana and to stigmatize those who consume it have been based upon hyperbole, stereotypes and outright lies. The initial push for cannabis criminalization, which began in earnest more than a century ago, had little to do...
Oct 13, 2024
Few adults turn to either healthcare providers or government agencies when seeking information about cannabis, according to nationwide survey data published in the Journal of Cannabis Research. Researchers with the University of Michigan at Ann Arbor surveyed over...
Oct 9, 2024
SetPoint Medical is planning to launch a clinical trial next year to investigate its nerve stimulator device, intending to support myelin repair, in people with relapsing-remitting multiple sclerosis (RRMS). The announcement comes after U.S. Food and Drug...
Sep 19, 2024
South San Francisco, CA — September 13, 2024 — Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY) announced today that the United States Food and Drug Administration (U.S. FDA) has approved Ocrevus Zunovo™ (ocrelizumab &...
Aug 26, 2024
The persistence of the COVID-19 pandemic has necessitated the development and widespread availability of methods to detect the COVID-19 virus in humans. COVID-19 tests, which were initially only available in healthcare facility settings, are now manufactured for home...
Aug 22, 2024
Abata Therapeutics is expected to launch a Phase 1 clinical trial by the end of the year to test ABA-101, its experimental therapy for progressive multiple sclerosis (MS), after getting a green light from the U.S. Food and Drug Administration (FDA). The FDA approved...
